Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Santen Pharma Malaysia is the regional subsidiary of Santen Pharmaceutical Co., Ltd., a leading global biopharmaceutical company dedicated exclusively to the field of ophthalmology. The company specializes in the research, development, and commercialization of innovative ophthalmic treatments and medical devices, addressing a wide range of eye conditions including glaucoma, dry eye disease, and retinal disorders. Santen holds a dominant market position in Asia and is recognized for its extensive portfolio of prescription eye drops and surgical products. The Malaysian entity serves as a critical hub for clinical support, regulatory affairs, and commercial operations within the Southeast Asian market. By focusing on specialized eye care, Santen aims to improve the quality of life for patients suffering from vision-impairing conditions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Santen Pharma Malaysia.